Menu Search
Equities

Nova Leap Health Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NVLPF:QXE

Nova Leap Health Corp

Actions
  • Price (USD)0.2334
  • Today's Change0.00 / 0.00%
  • Shares traded57.08k
  • 1 Year change+22.05%
  • Beta1.7598
Data delayed at least 15 minutes, as of Feb 05 2026 20:13 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nova Leap Health Corp. is a Canada-based acquisitive home health care services company operating in the United States (U.S.) and Canada. The Company, through its subsidiaries, provides various services to clients and families, including dementia care, companionship, personal care, respite care, cooking and meal preparation, light housekeeping, activities of daily living (ADL), transportation services, medication reminders, and medication administration by nursing staff. Its services are provided in private homes, assisted living communities, hospitals, nursing homes, hospice and rehabilitation centers and. The Company’s services are paid directly by clients, the Department of Veteran Affairs or through long-term care insurance programs. The Company operates in approximately ten different U.S. states within the New England, Southeastern, South-Central and Midwest regions as well as Nova Scotia, Canada.

  • Revenue in CAD (TTM)41.08m
  • Net income in CAD1.03m
  • Incorporated2015
  • Employees--
  • Location
    Nova Leap Health Corp7071 Bayers Road, Suite 3006HALIFAX B3L 2C2CanadaCAN
  • Phone+1 (902) 401-9480
  • Fax+1 (902) 446-2001
  • Websitehttps://novaleaphealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.